BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2646653)

  • 1. Drug metabolism in liver disease.
    Howden CW; Birnie GG; Brodie MJ
    Pharmacol Ther; 1989; 40(3):439-74. PubMed ID: 2646653
    [No Abstract]   [Full Text] [Related]  

  • 2. [Foreign matter metabolism by liver microsome fractions obtained from needle biopsy material examplified with coumarin-7-hydroxylase and 7-ethoxycoumarinhydroxylase in subject with a normal liver and in various human liver diseases].
    Kratz F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():527-31. PubMed ID: 612024
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of erythromycin on cyclosporine pharmacokinetics.
    Vereerstraeten P; Thiry P; Kinnaert P; Toussaint C
    Transplantation; 1987 Jul; 44(1):155-6. PubMed ID: 3603676
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of in vivo and in vitro drug metabolism in experimental hepatic injury in the rat.
    Willson RA; Hart FE; Hew JT
    Gastroenterology; 1979 Apr; 76(4):697-703. PubMed ID: 421997
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytochrome P-450 content and the ability of liver microsomes from patients undergoing abdominal surgery to alter the mutagenicity of a primary and secondary carcinogen.
    Czygan P; Greim H; Garro AJ; Hutterer F; Rudick J; Schaffner F; Popper H
    J Natl Cancer Inst; 1973 Dec; 51(6):1761-4. PubMed ID: 4587754
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic activation and detoxification of bromobenzene leading to cytotoxicity.
    Lau SS; Abrams GD; Zannoni VG
    J Pharmacol Exp Ther; 1980 Sep; 214(3):703-8. PubMed ID: 7400972
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of the liver for the biological activity of drugs].
    Ackermann E
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):3-8. PubMed ID: 5501425
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetics of preparations of lipoic acid and their effect on ATP synthesis, processes of microsomal and cytosol oxidation in hepatocytes in liver damage in man].
    Loginov AS; Nilova TV; Bendikov EA; Petrakov AV
    Farmakol Toksikol; 1989; 52(4):78-82. PubMed ID: 2509239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatopathies and drugs].
    González Macias J; De Castro del Pozo S
    Rev Esp Enferm Apar Dig; 1974; 44(2):175-86. PubMed ID: 4418081
    [No Abstract]   [Full Text] [Related]  

  • 10. Trimethadione: metabolism and assessment of hepatic drug-oxidizing capacity.
    Tanaka E; Funae Y
    Methods Enzymol; 1996; 272():163-9. PubMed ID: 8791774
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid peroxidation in dietary liver necrosis.
    Machado EA; Hamilton F
    Experientia; 1973 Aug; 29(8):951-3. PubMed ID: 4733310
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug metabolism and liver disease: a drug-gene-environment interaction.
    Zgheib NK; Branch RA
    Drug Metab Rev; 2017 Feb; 49(1):35-55. PubMed ID: 27957864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of liver diseases on pharmacokinetics of drugs].
    Lazowski J; Rewerski W
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):95-9. PubMed ID: 2216955
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: The significance and determinants of drug metabolism in man.
    Stevenson IH
    Digestion; 1973; 8(1):80-6. PubMed ID: 4776491
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic deactivation of furylfuramide by cytochrome P450 in human and rat liver microsomes.
    Shimada T; Yamazaki H; Shimura H; Tanaka R; Guengerich FP
    Carcinogenesis; 1990 Jan; 11(1):103-10. PubMed ID: 2403855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro metabolism of penicillium roqueforti toxin (PRT) and a structurally related compound, eremofortin A, by rat liver.
    Cacan M; Moreau S; Tailliez R
    Toxicology; 1977 Oct; 8(2):205-12. PubMed ID: 22144
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism.
    Farrell GC; Cooksley WG; Hart P; Powell LW
    Gastroenterology; 1978 Oct; 75(4):580-8. PubMed ID: 710827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hydrolysis and oxidation of drugs in various fractions of liver microsomes].
    REMMER H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1960; 238():36-7. PubMed ID: 14437293
    [No Abstract]   [Full Text] [Related]  

  • 19. Critical appraisal of 13C breath tests for microsomal liver function: aminopyrine revisited.
    Pijls KE; de Vries H; Nikkessen S; Bast A; Wodzig WK; Koek GH
    Liver Int; 2014 Apr; 34(4):487-94. PubMed ID: 24428683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etiology of hepatic injuries and sensitivity of the liver].
    Onishi H; Muto Y
    Nihon Rinsho; 1985 Jun; 43(6):1114-20. PubMed ID: 3900462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.